Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$349.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 11 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 14 most recent Form 4 transactions.
| Jun 10 | MIST | Milestone Pharmaceuticals… | AGRANT◆ | 77,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 29 | EBS | Emergent BioSolutions Inc. | AGRANT | 187,708 | — | — | +61.5% | Open the original filing on SEC.gov |
| Mar 31 | CADL | Candel Therapeutics, Inc. | AGRANT◆ | 2,795 | $4.11 | $11.5K | — | Open the original filing on SEC.gov |
| Mar 5 | EBS | Emergent BioSolutions Inc. | FTAX | 37,055 | $8.44 | $312.7K | -10.8% | Open the original filing on SEC.gov |
| Mar 3 | EBS | Emergent BioSolutions Inc. | AGRANT◆ | 252,194 | — | — | — | Open the original filing on SEC.gov |
| Jul 11, 2025 | MIST | Milestone Pharmaceuticals… | AGRANT◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 11, 2025 | MIST | Milestone Pharmaceuticals… | AGRANT◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 11, 2025 | MIST | Milestone Pharmaceuticals… | AGRANT | 100,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | CADL | Candel Therapeutics, Inc. | AGRANT | 64,239 | $4.67 | $300K | — | Open the original filing on SEC.gov |
| Jun 17, 2025 | CADL | Candel Therapeutics, Inc. | AGRANT◆ | 14,240 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | MIST | Milestone Pharmaceuticals… | AGRANT◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| May 13, 2025 | EBS | Emergent BioSolutions Inc. | PBUY | 60,000 | $5.83 | $349.8K | +21.2% | Open the original filing on SEC.gov |